• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 84-98 of 158 results

1015 Exhibit: US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿

Document IPR2018-00422, No. 1015-16 Exhibit - US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1008 Exhibit: Prosecution History of US Patent No9,693,979 App No 15159,972

Document IPR2018-00422, No. 1008-8 Exhibit - Prosecution History of US Patent No9,693,979 App No 15159,972 (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1010 Exhibit: US Publication No 20040157928 ¿¿¿Kim¿¿¿

Document IPR2018-00422, No. 1010 Exhibit - US Publication No 20040157928 ¿¿¿Kim¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1004 Exhibit: Prosecution History of US Patent No9,693,978 App No 60659,679

Document IPR2018-00422, No. 1004 Exhibit - Prosecution History of US Patent No9,693,978 App No 60659,679 (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1024 Exhibit: Jarkko Rautio et al, ¿¿¿In Vitro Evaluation ofAcyloxyalkyl Esters as Der...

Document IPR2018-00422, No. 1024 Exhibit - Jarkko Rautio et al, ¿¿¿In Vitro Evaluation ofAcyloxyalkyl Esters as Dermal Prodrugs ofKetoprofen and Naproxen,¿¿¿ Journal ofPharmaceutical Sciences, Vol 87...

cite Cite Document

1025 Exhibit: Letter from Sharon Hertz, Department OfHealth Human Services, to R...

Document IPR2018-00422, No. 1025 Exhibit - Letter from Sharon Hertz, Department OfHealth Human Services, to Roche Palo AltoLLC regarding NDA 18 965 November 10,2004 (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1027 Exhibit: H Sevelius et al, ¿¿¿Bioavailability of NaproxenSodium and Its Relation...

Document IPR2018-00422, No. 1027 Exhibit - H Sevelius et al, ¿¿¿Bioavailability of NaproxenSodium and Its Relationship to ClinicalAnalgesic Effects,¿¿¿ 10 Br J Clin Pharmac259 263 1980 (P.T.A.B. Jan. 14,...

cite Cite Document

1014 Exhibit: US Patent No 5,360,615 ¿¿¿Yu¿¿¿

Document IPR2018-00422, No. 1014 Exhibit - US Patent No 5,360,615 ¿¿¿Yu¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1015 Exhibit: US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿

Document IPR2018-00422, No. 1015 Exhibit - US Patent No 6,383,515 ¿¿¿Sawyer¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1001 Exhibit: Declaration of Peter Draper

Document IPR2018-00422, No. 1001 Exhibit - Declaration of Peter Draper (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1009 Exhibit: US Patent No 6,383,471 ¿¿¿Chen¿¿¿

Document IPR2018-00422, No. 1009 Exhibit - US Patent No 6,383,471 ¿¿¿Chen¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1013 Exhibit: US Patent No 5,641,512 ¿¿¿Cimileuca¿¿¿

Document IPR2018-00422, No. 1013 Exhibit - US Patent No 5,641,512 ¿¿¿Cimileuca¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1028 Exhibit: Banner Pharmacaps Inc NDA 21 920,Naproxen Sodium Capsules

Document IPR2018-00422, No. 1028 Exhibit - Banner Pharmacaps Inc NDA 21 920,Naproxen Sodium Capsules (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1020 Exhibit: US Patent No 6,251,426 ¿¿¿Gullapalli¿¿¿

Document IPR2018-00422, No. 1020 Exhibit - US Patent No 6,251,426 ¿¿¿Gullapalli¿¿¿ (P.T.A.B. Jan. 14, 2018)

cite Cite Document

1029 Exhibit: Robert Thornton Morrison Robert NeilsonBoyd, Organic Chemistry 4t...

Document IPR2018-00422, No. 1029 Exhibit - Robert Thornton Morrison Robert NeilsonBoyd, Organic Chemistry 4th ed, Allyn andBacon, Inc 1983 (P.T.A.B. Jan. 14, 2018)

cite Cite Document
<< 1 2 3 4 5 6 7 8 9 10 11 >>